Doctor profile · Federal record
Dr. Paul Griggs, MD
Ophthalmology Physician (CMS: Ophthalmology) · Seattle, WA
- NPI 1578584264
- Accepts Medicare
- MIPS 98.0 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
332 Ne Northgate Way
Seattle, WA 981256047
(206) 215-3850
fax (206) 215-3870 - Mailing address
-
22232 17Th Ave Se Ste 308
Bothell, WA 980217425
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- February 3, 2026
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Washington #MD00027226
- Medicaid
- WA #8118093
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578584264. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
38,567
Distinct HCPCS
10
Medicare allowed
$2,878,026
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 29,280 | 73 | $37 | |
92014 |
Established patient complete exam of visual system | 1,581 | 864 | $142 | |
67028 |
Injection of drug into eye | 1,486 | 311 | $152 | |
92134 |
Imaging of retina | 1,477 | 666 | $45 | |
J7999 |
Compounded drug, not otherwise classified | 1,014 | 180 | $92 | |
92250 |
Photography of the retina | 980 | 719 | $41 | |
92012 |
Established patient problem focused exam of visual system | 841 | 359 | $102 | |
J0178 |
Injection, aflibercept, 1 mg | 700 | 60 | $871 | |
92242 |
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 291 | 166 | $305 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 273 | 14 | $199 |
In context: peer comparison
Among 41 peers in this city , average services per provider: 258. This provider delivers 149× the peer median.Open Payments
Industry payments received
All-time total
$3,347
Transactions
24
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US Inc | 4 | $2,073.65 | |
| ABBVIE INC. | 7 | $304.61 | |
| Genentech USA, Inc. | 4 | $208.19 | |
| Apellis Pharmaceuticals, Inc. | 2 | $168.79 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $167.78 | |
| Cardinal Health 110 LLC | 1 | $150.00 | |
| Tarsus Pharmaceuticals, Inc. | 1 | $150.00 | |
| Bausch & Lomb Americas Inc. | 1 | $123.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,742
Patients
435
Total drug cost
$156,401
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 819 | 178 | $19,781 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 225 | 54 | $6,442 |
| Timolol Maleate | Generic | 153 | 43 | $2,717 |
| Brimonidine Tartrate | Generic | 103 | 31 | $4,165 |
| Prednisolone Acetate | Generic | 76 | 26 | $3,577 |
| Lumigan (Bimatoprost) | Brand | 59 | 14 | $27,679 |
| Dorzolamide Hcl | Generic | 58 | 14 | $1,536 |
| Brimonidine Tartrate-Timolol (Brimonidine Tartrate/Timolol) | Brand | 54 | 14 | $11,031 |
| Difluprednate | Generic | 54 | 21 | $7,212 |
| Restasis (Cyclosporine) | Brand | 48 | 21 | $48,269 |
Hospital affiliations
Frequently asked questions
What is Dr. Paul Griggs's medical specialty?
Dr. Paul Griggs practices Ophthalmology Physician in Seattle, WA.
Where does Dr. Paul Griggs practice?
Dr. Paul Griggs practices at 332 Ne Northgate Way, Seattle, WA 981256047. Office phone: 2062153850.
What is Dr. Paul Griggs's NPI?
Dr. Paul Griggs's National Provider Identifier (NPI) is 1578584264, issued by NPPES.
Does Dr. Paul Griggs accept Medicare assignment?
Yes. Dr. Paul Griggs accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paul Griggs commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Established patient complete exam of visual system (HCPCS 92014); Injection of drug into eye (HCPCS 67028). Source: CMS Medicare Physician & Other Practitioners file.